Teva Pharmaceutical Industries (NYSE:TEVA) shareholders are up 5.9% this past week, but still in the red over the last five years - Simply Wall St News
TEVA Soars after Catching Analyst Upgrade - TipRanks.com
TEVA Pharmaceutical (NYSE:TEVA)
Teva Pharmaceuticals on LinkedIn: NYSE Floor Talk | Teva Pharmaceuticals